Peter has over 20 years’ experience in the pharmaceutical industry. In his role at Quotient Sciences, he has been instrumental in identifying and implementing the innovative and flexible benefits of integrating pharmaceutical development and clinical testing in early research. Peter has served as a committee member for the U.K. Controlled Release Society and APS Biopharmaceutics focus group and in 2010 was named one of PharmaVOICE’s 100 most inspiring people in the life-sciences industry. He was appointed as an Honorary Professor in Pharmaceutical Sciences at Nottingham University in August 2015.
.svg)
